Chemclin Diagnostics Co. Ltd. A (688468) — Capital Reinvestment Ratio
Chemclin Diagnostics Co. Ltd. A (688468) has a Capital Reinvestment Ratio of 0.27x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥34.41 Million) in capital expenditures (CN¥9.16 Million). See Chemclin Diagnostics Co. Ltd. A free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Chemclin Diagnostics Co. Ltd. A Capital Reinvestment Ratio (2017–2025)
This chart tracks Chemclin Diagnostics Co. Ltd. A's Capital Reinvestment Ratio across 9 annual periods.
Annual Capital Reinvestment Ratio for Chemclin Diagnostics Co. Ltd. A (2017–2025)
Year-by-year Capital Reinvestment Ratio for Chemclin Diagnostics Co. Ltd. A from 2017 to 2025. For live market cap and broader valuation context, see Chemclin Diagnostics Co. Ltd. A (688468) total market value.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.74x | CN¥93.90 Million | CN¥69.88 Million | ▲ +16.3% |
| 2024 | 0.64x | CN¥167.95 Million | CN¥107.49 Million | ▼ -63.2% |
| 2023 | 1.74x | CN¥173.05 Million | CN¥301.37 Million | ▲ +240.0% |
| 2022 | 0.51x | CN¥244.56 Million | CN¥125.28 Million | ▲ +33.4% |
| 2021 | 0.38x | CN¥188.86 Million | CN¥72.55 Million | ▼ -29.9% |
| 2020 | 0.55x | CN¥151.95 Million | CN¥83.31 Million | ▲ +99.8% |
| 2019 | 0.27x | CN¥201.27 Million | CN¥55.24 Million | ▼ -16.4% |
| 2018 | 0.33x | CN¥147.68 Million | CN¥48.51 Million | ▼ -26.2% |
| 2017 | 0.45x | CN¥133.46 Million | CN¥59.43 Million | — |